Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation
- PMID: 30367690
- DOI: 10.1002/biof.1446
Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation
Abstract
Scleroderma is an inflammatory autoimmune disease which begins with inflammation due to tissue injury and advances to progressive accumulation of extracellular matrix resulting in scarring and hardening of the skin. Inflammation is a salutary response to tissue injury caused by varied factors. While inflammation is required for systematic wound healing, dysregulated chronic inflammation often leads to tissue scarring. Prominent role of inflammation in pathology and physiology makes it a double edge sword. The objective of this study was to investigate the role of Withaferin A (WFA), a steroidal lactone from Withania somnifera in a 28-day murine model of bleomycin-induced experimental scleroderma. Withaferin A was administered at two doses 2 and 4 mg/kg intraperitoneally for 28 days. At the time of study termination, we observed significant reduction in dorsal skin thickness. Our results indicate that WFA was able to sufficiently suppress pro-inflammatory phase of fibrosis, TGF-β/Smad signaling and also significantly repressed fibroblast conversion to myofibroblasts. Additionally, our study also demonstrated that WFA modulates FoxO3a-Akt-dependent NF-κβ/IKK-mediated inflammatory cascade, which is a prime signaling pathway in fibrogenesis. The findings of this study are persuasive of WFA as an antifibrotic agent with promising therapeutic effects in scleroderma. © 2018 BioFactors, 44(6):507-517, 2018.
Keywords: EMT; Withaferin A; bleomycin; inflammation; scleroderma.
© 2018 International Union of Biochemistry and Molecular Biology.
Similar articles
-
Withaferin A ameliorates renal injury due to its potent effect on inflammatory signaling.Biofactors. 2019 Sep;45(5):750-762. doi: 10.1002/biof.1534. Epub 2019 Jun 12. Biofactors. 2019. PMID: 31188510
-
Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma.Inflammopharmacology. 2019 Feb;27(1):139-149. doi: 10.1007/s10787-018-0527-4. Epub 2018 Sep 14. Inflammopharmacology. 2019. PMID: 30218238
-
Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.Life Sci. 2020 Nov 1;260:118399. doi: 10.1016/j.lfs.2020.118399. Epub 2020 Sep 9. Life Sci. 2020. PMID: 32918977
-
Matrix Stiffness: the Conductor of Organ Fibrosis.Curr Rheumatol Rep. 2018 Jan 19;20(1):2. doi: 10.1007/s11926-018-0710-z. Curr Rheumatol Rep. 2018. PMID: 29349703 Review.
-
Animal model of sclerotic skin induced by bleomycin: a clue to the pathogenesis of and therapy for scleroderma?Clin Immunol. 2002 Mar;102(3):209-16. doi: 10.1006/clim.2001.5169. Clin Immunol. 2002. PMID: 11890707 Review. No abstract available.
Cited by
-
Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management.Front Pharmacol. 2021 May 3;12:623795. doi: 10.3389/fphar.2021.623795. eCollection 2021. Front Pharmacol. 2021. PMID: 34012390 Free PMC article. Review.
-
Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics.Pharmaceutics. 2022 Mar 10;14(3):611. doi: 10.3390/pharmaceutics14030611. Pharmaceutics. 2022. PMID: 35335986 Free PMC article. Review.
-
Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases.Molecules. 2021 Apr 21;26(9):2407. doi: 10.3390/molecules26092407. Molecules. 2021. PMID: 33919088 Free PMC article. Review.
-
Withaferin A inhibits proliferation of human endometrial cancer cells via transforming growth factor-β (TGF-β) signalling.3 Biotech. 2021 Jul;11(7):323. doi: 10.1007/s13205-021-02878-6. Epub 2021 Jun 10. 3 Biotech. 2021. PMID: 34194907 Free PMC article.
-
Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies.Burns Trauma. 2022 Apr 8;10:tkac011. doi: 10.1093/burnst/tkac011. eCollection 2022. Burns Trauma. 2022. PMID: 35402628 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials